Day Lucy
SEC CIK 1914510 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | CFO | 118.4K | — | $12.8K | 6 | 2024-03-15 | 2026-02-20 |
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-20 | ANTX | AN2 Therapeutics, Inc. | Day Lucy | CFO | A - Grant | $0.00 | +38.0K | 118.4K | +47% | $0 |
| M | 2026-01-07 | 2026-01-05+ | ANTX | AN2 Therapeutics, Inc. | Day Lucy | CFO | S - Sale | $1.01 | -8,807 | 75.4K | -10% | -$8,862 |
| D | 2025-02-28 | 2025-02-26 | ANTX | AN2 Therapeutics, Inc. | Day Lucy | CFO | A - Grant | $0.00 | +46.5K | 79.2K | +142% | $0 |
| 2025-01-07 | 2025-01-03 | ANTX | AN2 Therapeutics, Inc. | Day Lucy | CFO | S - Sale | $1.34 | -2,957 | 32.7K | -8% | -$3,962 | |
| A | 2024-03-29 | 2024-03-15 | ANTX | AN2 Therapeutics, Inc. | Day Lucy | CFO | A - Grant | $0.00 | +27.5K | 30.6K | +879% | $0 |
| D | 2024-03-18 | 2024-03-15 | ANTX | AN2 Therapeutics, Inc. | Day Lucy | CFO | A - Grant | $0.00 | +27.5K | 30.6K | +879% | $0 |
Purchase Sale Sale after option exercise All abbreviations